
Geopolitics
The Pentagon Paid Anthropic $200 Million, Then Labeled It a Supply Chain Risk
A federal appeals court just upheld the Pentagon's blacklist of Anthropic, a month after a different judge called the same policy illegal retaliation. The exposure it targets runs through the compute deals funding Anthropic's growth, the same kind of dependency India is now racing to build.
By The Signal Editorial
September 26, 2026 · 8 min read
The Latest

Geopolitics
One Foreign Firm Builds More Missiles a Month Than India Manages All Year
Defence Secretary Rajesh Kumar Singh says India can't keep making 200 to 300 missiles a year when one Ukrainian firm makes 100 a month. He is also, as of this year, the man in charge of DRDO.
September 26, 2026

Geopolitics
Pakistan, Not Enrichment, Is Saudi Arabia's Fastest Path to a Bomb
A classified US assessment says Saudi Arabia has not ruled out building nuclear weapons. The faster hedge was never a centrifuge. It was a 2025 defense pact with a country that already has the bomb.
September 26, 2026

Markets
SEBI's New Entry Ticket Is Half What Its Own Rules Require
SEBI's board halved the price of entry into professional portfolio management, from a Rs 50 lakh regulatory floor to a new Rs 25 lakh route. The same package widens access at the top end too, for accredited investors and foreign funds.
September 26, 2026

Health
A Brain Signal, Not Willpower, Explains Why Dieters Regain Weight
India's GLP-1 market tripled in a year, but patients are stopping the drugs early over cost. New research on the brain and fat-cell mechanism behind weight regain says that stopping does not reset the body: it restarts the same signal that made the weight come off.
September 26, 2026

Health
Many Common Surgeries Work No Better Than a Fake Operation
A new review of sham-controlled surgical trials found most show no benefit over a fake operation. It is the same finding research has made for two decades, and it collides with India's insurance-driven appetite for elective surgery.
September 25, 2026

Business
The Fine for Fake Paneer Costs Less Than Amul Earns in a Minute
FSSAI's new draft rule reserves the word paneer for milk-derived products. The fine for breaking it hasn't moved since 2006, and it is smaller than a minute of Amul's revenue.
September 25, 2026
Business & Markets

Business
The Fine for Fake Paneer Costs Less Than Amul Earns in a Minute
FSSAI's new draft rule reserves the word paneer for milk-derived products. The fine for breaking it hasn't moved since 2006, and it is smaller than a minute of Amul's revenue.
September 25, 2026

Business
The IIT Placement Ban Assumes Companies Still Want to Hire
IITs just barred 22 companies from campus hiring for two years. The ban only works if those companies still want to come back, and corporate hiring itself is slowing.
September 25, 2026

Business
PB Fintech's Stock Crash Shows Its Premium Was Never About Technology
A regulatory paper on insurance commissions wiped a fifth off PB Fintech's stock in a single session, exposing how much of its business was commission, not technology.
September 24, 2026
Technology & Science

Technology
RatHat Steals Bank PINs Without Ever Touching the OTP
A new Android banking trojan reads PINs straight off the screen using the accessibility tool built for blind users. India's OTP defense never even sees it.
September 22, 2026
Technology
India's Semiconductor Success Turned It Into a Sabotage Target
ASML confirmed it has started operating in India the same week its minister warned the chip industry to brace for cyberattacks. The mission's success, not despite it, is what created the target.
September 21, 2026

Technology
The Lawsuit That Says AI Labs Colluded by Trying to Be Safe
Four subscribers say Anthropic, OpenAI, SpaceXAI and Google's joint safety pledge was an illegal slowdown pact. The case lands in a regulatory vacuum antitrust law never filled.
September 20, 2026
Health, Culture & Geopolitics

Health
A Brain Signal, Not Willpower, Explains Why Dieters Regain Weight
India's GLP-1 market tripled in a year, but patients are stopping the drugs early over cost. New research on the brain and fat-cell mechanism behind weight regain says that stopping does not reset the body: it restarts the same signal that made the weight come off.
September 26, 2026

Health
Many Common Surgeries Work No Better Than a Fake Operation
A new review of sham-controlled surgical trials found most show no benefit over a fake operation. It is the same finding research has made for two decades, and it collides with India's insurance-driven appetite for elective surgery.
September 25, 2026

Health
India Approved Dementia Drugs Most Hospitals Cannot Monitor
India's regulator has cleared two Alzheimer's drugs that can slow the disease. Most dementia patients are in the wrong stage to get them, and most hospitals lack the scans to give them safely.
September 24, 2026